# Total syntheses of highly oxidative Ryania diterpenoids facilitated by innovations in synthetic strategies

**Authors:** Zhi-Qi Cao, Jin-Bao Qiao, Yu-Ming Zhao

PMC · DOI: 10.3762/bjoc.21.198 · Beilstein Journal of Organic Chemistry · 2025-11-19

## TL;DR

This paper reviews innovative synthetic methods used to create complex Ryania diterpenoids, which are promising for cardiovascular disease treatments.

## Contribution

The paper highlights novel ring-construction methods and strategies for synthesizing highly oxidized Ryania diterpenoids.

## Key findings

- Innovative synthetic strategies significantly improve the efficiency of creating complex Ryania diterpenoids.
- Ryanodine and its derivatives show potential as therapeutic agents for cardiovascular diseases.
- Advanced methods enable the synthesis of natural products with intricate structures and high oxidation states.

## Abstract

Innovations in synthetic methods and strategic design serve as the primary driving forces behind the advancement of organic synthetic chemistry. With rapidly evolving organic synthesis technologies, a diverse array of novel methods and sophisticated strategies continues to emerge. These approaches not only complement and synergize with one another but also significantly enhance synthetic efficiency, reduce costs, and provide robust solutions to challenges encountered in the synthesis of complex molecular architectures. Ryania diterpenes are natural products characterized by intricate structures and high oxidation states. Biological studies have revealed that the family member ryanodine has a specific regulatory effect on myocardial calcium ion channels (PyR). Since only a limited number of compounds have been reported to act by modifying this receptor, ryanodine and its derivatives are potential therapeutic agents for treating cardiovascular diseases. This article focuses on reviewing the efficient application of ring-construction methods and synthetic strategies in the total synthesis of highly oxidized Ryania diterpenoid natural products, emphasizing the pivotal role of novel synthetic methods and strategic innovations.

## Full-text entities

- **Diseases:** cardiovascular diseases (MESH:D002318)
- **Chemicals:** Ryania diterpenes (-), ryanodine (MESH:D012433)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12642944/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12642944/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC12642944/full.md

---
Source: https://tomesphere.com/paper/PMC12642944